+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ALPA

Share Price

 

 

Performance

  • Today's Low
  • ₹67
  • Today's High
  • ₹70
  • 52 Week Low
  • ₹46
  • 52 Week High
  • ₹108
  • Open Price₹70
  • Previous Close₹68
  • Volume12,878
  • 50 DMA₹68.31
  • 100 DMA₹69.49
  • 200 DMA₹75.52

Chart

Smart Investing Starts Here Start SIP with for Steady Growth!

Invest Now

Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 10
  • PEG Ratio
  • -0.4
  • Market Cap Cr
  • 142
  • P/B Ratio
  • 0.8
  • Average True Range
  • 2.96
  • EPS
  • 7.13
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.22
  • RSI
  • 45.34
  • MFI
  • 28.52

Latest Stock News Updates

West Asia crisis: Pilots' body ALPA India seeks centralised risk assessment

Pilots' grouping ALPA India on Friday urged the civil aviation ministry and regulator DGCA to suspend flight operations into high-risk conflict zones till a centralised risk assessment is carried out amid the escalating West Asia crisis. Stressing the need for having war-risk insurance, it also said the watchdog should mandate immediate disclosure and verification of valid insurance coverage, including war-risk clauses, for all crew operating into or near conflict zones. The Middle East conflict involving the US, Israel and Iran has significantly disrupted flight operations, and airlines have curtailed their services. In a letter to DGCA, Airline Pilots' Association of India (ALPA India) said commercial airlines do not possess the requisite intelligence, surveillance capabilities, or geopolitical risk assessment infrastructure necessary to adequately evaluate threats in active conflict environments. The Directorate General of Civil Aviation (DGCA) should immediately review and...

Ensure airlines assess risk before flying in conflict-hit areas: ALPA

Pilots' body ALPA India on Tuesday asked its members to ensure that airline operators carry out "appropriate operational risk assessments" before planning flights in or near conflict-affected areas. The Air Line Pilots Association (ALPA) India, in an advisory to all pilots under an Indian licence, said that the pilots must remain aware that the risk environment in conflict-affected areas can change rapidly and without adequate warning. The advisory has come amid the escalating war in West Asia, involving the US, Israel and Iran, which has led to cancellations of a number of flights due to airspace closures since February 28. The pilots' body said that members are advised to take note of the potential implications related to aviation insurance coverage, particularly with respect to war-risk clauses. Under certain circumstances, insurance providers may withdraw or limit coverage for operations conducted in designated conflict zones or high-risk airspaces, it said. ALPA India is an .

ALPA India to brief Parliamentary Standing Committee on FDTL gaps

ALPA India has repeatedly warned that poor fatigue management can affect flight safety; they will also brief members of Parliament on the rise in GPS spoofing incidents reported at major airports in recent months

Financials

Technicals

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alpa Laboratories has an operating revenue of Rs. 105.81 Cr. on a trailing 12-month basis. An annual revenue de-growth of -10% needs improvement, Pre-tax margin of 15% is great, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 60 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2026-02-11 Quarterly Results
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results & A.G.M.
2025-05-28 Audited Results

Shareholding Pattern

57.19%
0.38%
36.75%
5.68%

FAQs

share price is ₹67 As on 22 June, 2026 | 22:42

The Market Cap of is ₹142.2 Cr As on 22 June, 2026 | 22:42

The P/E ratio of is 10 As on 22 June, 2026 | 22:42

The PB ratio of is 0.8 As on 22 June, 2026 | 22:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23